ReviewCell cycle (Georgetown, Tex.)
Epithelial-mesenchymal-associated non-coding RNAs as Breast cancer metastasis biomarkers.
Review in Cell cycle (Georgetown, Tex.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating multi-omics and clinical management in breast cancer: a comprehensive review.Discover oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) is identified as a significant cause of cancer mortality in the female population. The recurrence of initial tumors and the metastasis to remote areas of the body are significant factors leading to the mortality linked with BC. Despite the advancements in diagnostic and therapeutic approaches, a comprehensive understanding of the molecular mechanisms underlying metastasis is still unclear, particularly regarding the regulatory role of non-coding RNAs (ncRNAs) in epithelial-mesenchymal transition (EMT). Different categories of ncRNAs, including microRNAs (miRNAs), circular RNAs (circRNAs), and long ncRNAs (lncRNAs), can manage the complex regulatory frameworks of EMT at various levels. Since dysregulation of ncRNAs is associated with key processes in EMT, investigating them as valuable tools for identifying the metastatic potential of tumors at an early stage could significantly increase diagnostic accuracy and improve patient outcomes, particularly in BC. This review aims to bridge this gap by systematically summarizing current insights into the interplay between EMT and various classes of ncRNAs in the context of BC progression. We discuss the molecular pathways through which ncRNAs regulate EMT, their impact on metastasis and explore their potential as diagnostic biomarkers and therapeutic targets. By providing an integrative overview of recent findings, this article highlights unresolved questions and proposes directions for future research, offering a valuable resource for researchers and clinicians involved in breast cancer biology and treatment development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.